Related Experiment Video
Updated: Sep 1, 2025

07:15
A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
Published on: July 28, 2020
9.7K
Wide Resection of Extremity/Truncal Soft Tissue Sarcomas
1Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Elm and Carlton Streets, Buffalo, NY 14263, USA.
The Surgical Clinics of North America
|August 11, 2022
Summary
Wide resection with negative margins is the primary curative treatment for sarcoma. Surgical planning must consider margin size, tumor spillage, and the potential benefits of neoadjuvant therapies for optimal outcomes.
Area of Science:
- Surgical Oncology
- Orthopedic Oncology
- Sarcoma Research
Background:
- Sarcomas are malignant tumors requiring precise surgical management.
- Achieving negative margins is crucial for potentially curative sarcoma treatment.
- Microscopic tumor extension necessitates careful surgical planning and execution.
Purpose of the Study:
- To outline the principles of surgical resection for potentially curative sarcoma treatment.
- To emphasize the importance of margin status and surgical technique in sarcoma management.
- To discuss the role of multimodal therapy in conjunction with surgical intervention.
Main Methods:
- Review of established surgical principles for wide local excision of sarcomas.
- Discussion of margin planning, including ideal measurements and considerations for critical structures.
- Emphasis on techniques to prevent tumor spillage during resection.
Main Results:
- Negative margin wide resection is the cornerstone of potentially curative sarcoma surgery.
- Adherence to planned margins (1-2 cm) is recommended, with exceptions for oncologically equivalent tissues or critical structures.
- Preoperative discussion of radiation and/or chemotherapy is vital due to potential benefits.
Conclusions:
- Optimal surgical management of sarcoma involves achieving negative margins through wide resection.
- Limb salvage is prioritized, with amputation reserved as a last resort.
- Multidisciplinary discussion regarding neoadjuvant therapies is essential for comprehensive sarcoma care.

